文献速递心血管PET

全球单光子发射计算机断层扫描心肌灌注成像诊断参考水平:INCAPS研究结果

Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-08-19

该研究基于INCAPS跨国横断面注册的7103例SPECT MPI研究,按世界区域和全球汇总计算诊断参考水平(DRL)与可达到给药活度(AAA)。全球1日法锝-99m显像剂DRL为首次11.2 mCi、第二次32.0 mCi,多日法为首次23.0 mCi、第二次24.0 mCi;应激-only法DRL为18.0 mCi、AAA为12.5 mCi。各区域间DRL与AAA存在显著差异。

要点

  • 全球1日法SPECT MPI的DRL为首次11.2 mCi、第二次32.0 mCi。
  • 全球多日法DRL为首次23.0 mCi、第二次24.0 mCi。
  • 应激-only法全球DRL 18.0 mCi、AAA 12.5 mCi。

诊断标准与关键数值

  • 全球1日法锝-99m静息-负荷或负荷-静息研究DRL:首次剂量11.2 mCi,第二次剂量32.0 mCi。
  • 全球多日法锝-99m研究DRL:首次剂量23.0 mCi,第二次剂量24.0 mCi。
  • 全球1日法AAA:首次剂量10.1 mCi,第二次剂量28.0 mCi。
  • 全球多日法AAA:首次剂量17.8 mCi,第二次剂量18.7 mCi。
  • 应激-only锝-99m研究全球DRL 18.0 mCi,AAA 12.5 mCi。

临床应用与阅片要点

  • 区域DRL可用于将单个实验室方案与区域趋势进行比较。
  • 各区域间DRL与AAA存在显著差异,阅片和报告时可参考所在区域的参考水平。
  • 北美应激-first成像仅占7%,而其他区域为26%至92%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to establish worldwide and regional diagnostic reference levels (DRLs) and achievable administered activities (AAAs) for single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI).

BACKGROUND: Reference levels serve as radiation dose benchmarks to compare individual laboratories against aggregated data, helping to identify sites in greatest need of dose reduction interventions. DRLs for SPECT MPI have previously been derived from national or regional registries. To date there have been no multiregional reports of DRLs for SPECT MPI from a single standardized dataset.

METHODS: Data were submitted voluntarily to the INCAPS (International Atomic Energy Agency Nuclear Cardiology Protocols Study), a cross-sectional, multinational registry of MPI protocols. A total of 7,103 studies were included. DRLs and AAAs were calculated by protocol for each world region and for aggregated worldwide data.

RESULTS: The aggregated worldwide DRLs for rest-stress or stress-rest studies employing technetium Tc 99m-labeled radiopharmaceuticals were 11.2 mCi (first dose) and 32.0 mCi (second dose) for 1-day protocols, and 23.0 mCi (first dose) and 24.0 mCi (second dose) for multiday protocols. Corresponding AAAs were 10.1 mCi (first dose) and 28.0 mCi (second dose) for 1-day protocols, and 17.8 mCi (first dose) and 18.7 mCi (second dose) for multiday protocols. For stress-only technetium Tc 99m studies, the worldwide DRL and AAA were 18.0 mCi and 12.5 mCi, respectively. Stress-first imaging was used in 26% to 92% of regional studies except in North America where it was used in just 7% of cases. Significant differences in DRLs and AAAs were observed between regions.

CONCLUSIONS: This study reports reference levels for SPECT MPI for each major world region from one of the largest international registries of clinical MPI studies. Regional DRLs may be useful in establishing or revising guidelines or simply comparing individual laboratory protocols to regional trends. Organizations should continue to focus on establishing standardized reporting methods to improve the validity and comparability of regional DRLs.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Hirschfeld CB, Dondi M, Pascual TNB, et al. Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS. JACC Cardiovasc Imaging. 2020. PMID: 32828783. doi:10.1016/j.jcmg.2020.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。